应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SMMT Summit Therapeutics PLC
盘后交易 11-22 17:26:54 EST
19.00
+0.58
+3.15%
盘后
19.05
+0.05
+0.26%
17:23 EST
最高
19.44
最低
18.50
成交量
150.70万
今开
18.50
昨收
18.42
日振幅
5.10%
总市值
140.12亿
流通市值
21.55亿
总股本
7.37亿
成交额
2,868万
换手率
1.33%
流通股本
1.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Summit Therapeutics Inc.盘中异动 下午盘急速拉升5.05%报19.35美元
市场透视 · 02:35
Summit Therapeutics Inc.盘中异动 下午盘急速拉升5.05%报19.35美元
Summit Therapeutics Inc.盘中异动 下午盘急速上涨5.11%报19.95美元
市场透视 · 11-20
Summit Therapeutics Inc.盘中异动 下午盘急速上涨5.11%报19.95美元
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.07%
市场透视 · 11-18
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.07%
Summit Therapeutics Inc.盘中异动 快速下挫5.14%
市场透视 · 11-16
Summit Therapeutics Inc.盘中异动 快速下挫5.14%
Summit Therapeutics Inc.盘中异动 下午盘大幅跳水5.03%报19.72美元
市场透视 · 11-14
Summit Therapeutics Inc.盘中异动 下午盘大幅跳水5.03%报19.72美元
Summit Therapeutics Inc.2024财年第三财季实现净利润-56.25百万美元,同比减少164.46%
市场透视 · 11-09
Summit Therapeutics Inc.2024财年第三财季实现净利润-56.25百万美元,同比减少164.46%
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.35%报19.30美元
市场透视 · 11-06
Summit Therapeutics Inc.盘中异动 早盘股价大跌5.35%报19.30美元
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.06%
市场透视 · 11-04
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.06%
Summit Therapeutics Inc.盘中异动 早盘大幅上涨5.06%
市场透视 · 11-01
Summit Therapeutics Inc.盘中异动 早盘大幅上涨5.06%
异动解读 | 业绩亏损大增,Summit Therapeutics生物股重挫14.5%
异动解读 · 10-31
异动解读 | 业绩亏损大增,Summit Therapeutics生物股重挫14.5%
异动解读 | Summit Therapeutics PLC 财报亏损大幅超预期 股价大跌12%
异动解读 · 10-30
异动解读 | Summit Therapeutics PLC 财报亏损大幅超预期 股价大跌12%
Summit Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
Reuters · 10-30
Summit Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
Summit Therapeutics Inc.盘中异动 早盘快速下挫7.10%
市场透视 · 10-30
Summit Therapeutics Inc.盘中异动 早盘快速下挫7.10%
Summit Therapeutics Inc.盘中异动 临近午盘大幅下跌5.08%报21.11美元
市场透视 · 10-29
Summit Therapeutics Inc.盘中异动 临近午盘大幅下跌5.08%报21.11美元
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.03%
市场透视 · 10-28
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.03%
Summit Therapeutics Inc 预计每股亏损 7 美分 - 财报前瞻
Reuters · 10-28
Summit Therapeutics Inc 预计每股亏损 7 美分 - 财报前瞻
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.08%报20.45美元
市场透视 · 10-25
Summit Therapeutics Inc.盘中异动 早盘股价大涨5.08%报20.45美元
英国9月汽车产量连续7个月下滑
财经网 · 10-25
英国9月汽车产量连续7个月下滑
Summit Therapeutics Inc.盘中异动 大幅下跌5.05%
市场透视 · 10-24
Summit Therapeutics Inc.盘中异动 大幅下跌5.05%
Summit Therapeutics Inc.盘中异动 早盘急速下跌5.03%报22.28美元
市场透视 · 10-17
Summit Therapeutics Inc.盘中异动 早盘急速下跌5.03%报22.28美元
暂无数据
公司概况
公司名称:
Summit Therapeutics PLC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立,特拉华州的一家公司(“New Summit”)已成为该公司的后续发行方。该公司是一家生物制药公司,专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法,旨在提高生活质量,延长潜在寿命,并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。
发行价格:
--
{"stockData":{"symbol":"SMMT","market":"US","secType":"STK","nameCN":"Summit Therapeutics PLC","latestPrice":19,"timestamp":1732309200000,"preClose":18.42,"halted":0,"volume":1507034,"hourTrading":{"tag":"盘后","latestPrice":19.05,"preClose":19,"latestTime":"17:23 EST","volume":28768,"amount":546760.350336,"timestamp":1732314191915},"delay":0,"floatShares":113435221,"shares":737448146,"eps":-0.277208,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.58,"latestTime":"11-22 17:26:54 EST","open":18.5,"high":19.44,"low":18.5,"amount":28677398.211088,"amplitude":0.051031,"askPrice":19.38,"askSize":4,"bidPrice":18.86,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.277208,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":1,"listingDate":1425531600000,"adjPreClose":18.42,"adrRate":5,"preHourTrading":{"tag":"盘前","latestPrice":18.5,"preClose":18.42,"latestTime":"09:29 EST","volume":9739,"amount":181164.829305,"timestamp":1732285799915},"postHourTrading":{"tag":"盘后","latestPrice":19.05,"preClose":19,"latestTime":"17:23 EST","volume":28768,"amount":546760.350336,"timestamp":1732314191915},"volumeRatio":0.867994,"impliedVol":0.5508,"impliedVolPercentile":0.0159},"requestUrl":"/m/hq/s/SMMT/tweets","defaultTab":"tweets","newsList":[{"id":"2485414290","title":"Summit Therapeutics Inc.盘中异动 下午盘急速拉升5.05%报19.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485414290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485414290?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:35","pubTimestamp":1732300546,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时35分,Summit Therapeutics Inc.股票出现异动,股价快速拉升5.05%。截至发稿,该股报19.35美元/股,成交量78.4472万股,换手率0.11%,振幅4.53%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123023546971a828b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123023546971a828b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LU2488822045.USD","SMMT"],"gpt_icon":0},{"id":"2484772229","title":"Summit Therapeutics Inc.盘中异动 下午盘急速上涨5.11%报19.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484772229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484772229?lang=zh_cn&edition=full","pubTime":"2024-11-20 03:53","pubTimestamp":1732046016,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日03时53分,Summit Therapeutics Inc.股票出现异动,股价大幅上涨5.11%。截至发稿,该股报19.95美元/股,成交量78.4552万股,换手率0.11%,振幅7.48%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.41%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035336a2467d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120035336a2467d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SMMT","LU2488822045.USD"],"gpt_icon":0},{"id":"2484672440","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484672440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484672440?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:40","pubTimestamp":1731944459,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时40分,Summit Therapeutics Inc.股票出现波动,股价急速上涨5.07%。截至发稿,该股报19.24美元/股,成交量36.6921万股,换手率0.05%,振幅6.06%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118234059971a7390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118234059971a7390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LENZ","BK4139","LU2488822045.USD"],"gpt_icon":0},{"id":"2483858292","title":"Summit Therapeutics Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483858292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483858292?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:51","pubTimestamp":1731700317,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时51分,Summit Therapeutics Inc.股票出现异动,股价大幅下跌5.14%。截至发稿,该股报18.45美元/股,成交量127.948万股,换手率0.17%,振幅4.88%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为3.70%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111603515798e4305b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111603515798e4305b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SMMT","BK4139","LENZ"],"gpt_icon":0},{"id":"2483185244","title":"Summit Therapeutics Inc.盘中异动 下午盘大幅跳水5.03%报19.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483185244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483185244?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:11","pubTimestamp":1731528710,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时11分,Summit Therapeutics Inc.股票出现波动,股价急速下挫5.03%。截至发稿,该股报19.72美元/股,成交量127.503万股,换手率0.17%,振幅9.78%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.49%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114041151a234f7af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114041151a234f7af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LU2488822045.USD","SMMT"],"gpt_icon":0},{"id":"2482248505","title":"Summit Therapeutics Inc.2024财年第三财季实现净利润-56.25百万美元,同比减少164.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482248505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482248505?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081621,"startTime":"0","endTime":"0","summary":"11月9日,Summit Therapeutics Inc.公布财报,公告显示公司2024财年第三财季净利润为-56.25百万美元,同比减少164.46%;其中营业收入为0.00美元,每股基本收益为-0.08美元。机构评级:截至2024年11月9日,当前有4家机构对Summit Therapeutics Inc.目标价做出预测,其中目标均价为34.75美元,其中最低目标价为23.00美元,最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000029abae6d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000029abae6d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT"],"gpt_icon":0},{"id":"2481857729","title":"Summit Therapeutics Inc.盘中异动 早盘股价大跌5.35%报19.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481857729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481857729?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:36","pubTimestamp":1730903816,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时36分,Summit Therapeutics Inc.股票出现异动,股价急速下跌5.35%。截至发稿,该股报19.30美元/股,成交量18.5413万股,换手率0.03%,振幅6.57%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.18%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622365698e40e1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622365698e40e1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","BK4139","LU2488822045.USD","LENZ"],"gpt_icon":0},{"id":"2480474580","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480474580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480474580?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:44","pubTimestamp":1730735047,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时44分,Summit Therapeutics Inc.股票出现异动,股价快速拉升5.06%。截至发稿,该股报19.95美元/股,成交量52.8117万股,换手率0.07%,振幅5.90%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.28%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234407971a4340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104234407971a4340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LENZ","LU2488822045.USD","BK4139"],"gpt_icon":0},{"id":"2480894828","title":"Summit Therapeutics Inc.盘中异动 早盘大幅上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480894828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480894828?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:47","pubTimestamp":1730468857,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时47分,Summit Therapeutics Inc.股票出现波动,股价大幅拉升5.06%。截至发稿,该股报19.53美元/股,成交量19.3627万股,换手率0.03%,振幅3.60%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.01%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214737971a3db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214737971a3db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","LU2488822045.USD","BK4139"],"gpt_icon":0},{"id":"1164625903","title":"异动解读 | 业绩亏损大增,Summit Therapeutics生物股重挫14.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164625903","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164625903?lang=zh_cn&edition=full","pubTime":"2024-10-31 13:14","pubTimestamp":1730351690,"startTime":"0","endTime":"0","summary":"生物制药公司Summit Therapeutics PLC10月30日股价重挫,一度大跌14.5%,报20.28美元/股。盘中一度大跌12%,成交量显著放大,引发市场广泛关注。根据公司最新发布的财报,这一大跌主要是因为公司最新季度业绩亏损水平大幅超出华尔街预期所致。数据显示,2024年第三季度,Summit Therapeutics净亏损高达5630万美元,每股亏损8美分,远高于分析师预期的每股亏损6-7美分。一些投资者担忧公司在竞争激烈的生物制药行业内难以取得突破,因此部分机构选择逃离该股,加剧了股价下跌压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"gpt_icon":0},{"id":"1173258879","title":"异动解读 | Summit Therapeutics PLC 财报亏损大幅超预期 股价大跌12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173258879","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173258879?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:27","pubTimestamp":1730302033,"startTime":"0","endTime":"0","summary":"Summit Therapeutics PLC今日盘中一度大跌12%,报20.28美元/股,成交量放大。分析师认为,公司最新季度财报糟糕,业绩大幅亏损超预期是导致股价重挫的主要原因。财报显示,Summit Therapeutics截至9月30日的单季度净亏损高达5630万美元,每股亏损8美分,远超华尔街分析师此前预计的每股亏损6-7美分。Summit Therapeutics主攻严重传染病新型抗生素领域,其产品管线旗舰ridinilazole目前仍处于开发阶段,项目前景存在较大不确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"gpt_icon":0},{"id":"2479780187","title":"Summit Therapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2479780187","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479780187?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:22","pubTimestamp":1730301760,"startTime":"0","endTime":"0","summary":" * Summit Therapeutics Inc 报告了截至9月30日的季度调整后每股亏损8美分。华尔街预期为每股-7美分至-6美分。* Summit Therapeutics Inc 报告的季度每股收益为亏损 8 美分。* 该公司当季亏损 5630 万美元。* Summit Therapeutics Inc 的股价本季度下跌了 0.3%,今年迄今为止上涨了 736.4%。10月30日 - 预测变化 * 过去三个月,分析师的平均盈利预期下降了约 0.3%。华尔街对 Summit Therapeutics Inc 的 12 个月目标价中位数为 40.00 美元。本摘要由 LSEG 10 月 30 日 03:21 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","LU2488822045.USD","SMMT"],"gpt_icon":0},{"id":"2479785317","title":"Summit Therapeutics Inc.盘中异动 早盘快速下挫7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479785317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479785317?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:31","pubTimestamp":1730295104,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时31分,Summit Therapeutics Inc.股票出现波动,股价急速跳水7.10%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.30%。其相关个股中,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.涨幅较大,Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1736.42%、98.93%、15.89%,振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Cormedix Inc.,振幅分别为22.66%、11.49%、10.79%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213144ab84424c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030213144ab84424c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK4139","SMMT","LENZ"],"gpt_icon":0},{"id":"2479238390","title":"Summit Therapeutics Inc.盘中异动 临近午盘大幅下跌5.08%报21.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479238390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479238390?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:35","pubTimestamp":1730216104,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时35分,Summit Therapeutics Inc.股票出现波动,股价快速下挫5.08%。截至发稿,该股报21.11美元/股,成交量64.3823万股,换手率0.09%,振幅5.35%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029233504ab7f677e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029233504ab7f677e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU2488822045.USD","SMMT","LENZ"],"gpt_icon":0},{"id":"2478489987","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478489987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478489987?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:53","pubTimestamp":1730123587,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时53分,Summit Therapeutics Inc.股票出现波动,股价急速上涨5.03%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.涨幅较大,Tc Biopharm Plc、Viracta Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为577.16%、50.99%、39.31%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.,振幅分别为87.13%、45.41%、29.24%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215308ab7bd004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215308ab7bd004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","LU2488822045.USD","BK4139"],"gpt_icon":0},{"id":"2478483303","title":"Summit Therapeutics Inc 预计每股亏损 7 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2478483303","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478483303?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:08","pubTimestamp":1730120901,"startTime":"0","endTime":"0","summary":" * Summit Therapeutics Inc 预计将于10月30日公布截至2024年9月30日的财报。* * LSEG的分析师平均预计Summit Therapeutics Inc每股亏损7美分。* 华尔街对 Summit Therapeutics Inc 的 12 个月目标价中位数为 40.00 美元,高于其上一次收盘价 21.26 美元。10月28日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SMMT"],"gpt_icon":0},{"id":"2478176939","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.08%报20.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478176939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478176939?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:22","pubTimestamp":1729866133,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时22分,Summit Therapeutics Inc.股票出现波动,股价急速上涨5.08%。截至发稿,该股报20.45美元/股,成交量36.7914万股,换手率0.05%,振幅3.83%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522221398e3e861&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522221398e3e861&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU2488822045.USD","BK4139","SMMT"],"gpt_icon":0},{"id":"2478416066","title":"英国9月汽车产量连续7个月下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2478416066","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478416066?lang=zh_cn&edition=full","pubTime":"2024-10-25 10:48","pubTimestamp":1729824480,"startTime":"0","endTime":"0","summary":"日前,英国汽车制造商和贸易商协会(SMMT)发布行业数据显示,今年9月份英国汽车产量连续第七个月下滑。SMMT表示,9月份英国共有70039辆汽车下线,同比下降20.6%。其中电动化车型(包括纯电动汽车、插电式混合动力汽车和混合动力汽车)产量为21309辆,同比下降37%。(中国汽车报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-10-25/doc-incttsyf1824339.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-10-25/doc-incttsyf1824339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2488822045.USD","SMMT","BK4139"],"gpt_icon":0},{"id":"2477813550","title":"Summit Therapeutics Inc.盘中异动 大幅下跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477813550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477813550?lang=zh_cn&edition=full","pubTime":"2024-10-24 02:05","pubTimestamp":1729706723,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日02时05分,Summit Therapeutics Inc.股票出现波动,股价快速下跌5.05%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.44%。其相关个股中,Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大,Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为1867.49%、1536.69%、508.57%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.,振幅分别为109.26%、71.86%、68.32%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020523971a1ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024020523971a1ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK4139","SMMT","LENZ"],"gpt_icon":0},{"id":"2476179934","title":"Summit Therapeutics Inc.盘中异动 早盘急速下跌5.03%报22.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476179934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476179934?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:17","pubTimestamp":1729174650,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时17分,Summit Therapeutics Inc.股票出现波动,股价大幅下跌5.03%。截至发稿,该股报22.28美元/股,成交量79.3863万股,换手率0.11%,振幅6.35%。Summit Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Summit Therapeutics Inc.公司简介:Summit Therapeutics Inc是一家生物制药公司,专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221730a1e16a4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221730a1e16a4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LU2488822045.USD","SMMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.smmttx.com","stockEarnings":[{"period":"1week","weight":-0.053},{"period":"1month","weight":-0.1054},{"period":"3month","weight":0.4083},{"period":"6month","weight":4.4497},{"period":"1year","weight":8.4462},{"period":"ytd","weight":6.0575}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立,特拉华州的一家公司(“New Summit”)已成为该公司的后续发行方。该公司是一家生物制药公司,专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法,旨在提高生活质量,延长潜在寿命,并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.110315},{"month":2,"riseRate":0.444444,"avgChangeRate":0.031629},{"month":3,"riseRate":0.444444,"avgChangeRate":0.039733},{"month":4,"riseRate":0.4,"avgChangeRate":0.012892},{"month":5,"riseRate":0.6,"avgChangeRate":0.133904},{"month":6,"riseRate":0.3,"avgChangeRate":-0.112221},{"month":7,"riseRate":0.6,"avgChangeRate":0.073302},{"month":8,"riseRate":0.5,"avgChangeRate":0.002422},{"month":9,"riseRate":0.4,"avgChangeRate":0.095771},{"month":10,"riseRate":0.3,"avgChangeRate":-0.044184},{"month":11,"riseRate":0.4,"avgChangeRate":-0.012248},{"month":12,"riseRate":0.555556,"avgChangeRate":0.442254}],"exchange":"NASDAQ","name":"Summit Therapeutics PLC","nameEN":"Summit Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Summit Therapeutics PLC,SMMT,Summit Therapeutics PLC股票,Summit Therapeutics PLC股票老虎,Summit Therapeutics PLC股票老虎国际,Summit Therapeutics PLC行情,Summit Therapeutics PLC股票行情,Summit Therapeutics PLC股价,Summit Therapeutics PLC股市,Summit Therapeutics PLC股票价格,Summit Therapeutics PLC股票交易,Summit Therapeutics PLC股票购买,Summit Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}